What is the current market size and future outlook for the implantable cardioverter defibrillators (icds) market?
The implantable cardioverter defibrillators (ICDs) market size has grown strongly in recent years. It will grow from $3.76 billion in 2024 to $3.99 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to increasing incidence of sudden cardiac arrest, inclusion of implantable cardioverter defibrillator in secondary prevention of sudden cardiac arrest, growing public awareness, rise in the aging population, supportive policies by governments and healthcare organizations, increased healthcare access.
The implantable cardioverter defibrillators (ICDs) market size is expected to see strong growth in the next few years. It will grow to $4.99 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to growing acceptance of implantable defibrillators, rise in demand for more personalized cardiac care, rising prevalence of cardiac rhythm disorders, rising demand in emerging markets. Major trends in the forecast period include technological advancements, introduction of subcutaneous ICD that avoid transvenous leads, demand for combination ICD devices with pacemaker functionality, enhancing sensing and detection algorithms, continuous advancements in wireless charging and battery technology, integration of artificial intelligence (AI) in healthcare and data analytics.
Get Your Free Sample of The Global Implantable Cardioverter Defibrillators (ICDs) Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20839&type=smp
How has the implantable cardioverter defibrillators (icds) market evolved, and what factors have shaped its growth?
The increasing prevalence of cardiovascular diseases (CVDs) is expected to propel the growth of the implantable cardioverter defibrillators (ICDs) market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions such as heart attacks, strokes, and hypertension, often caused by factors like poor diet, lack of exercise, smoking, and genetics. The increasing prevalence of cardiovascular diseases is primarily driven by aging populations, unhealthy lifestyle choices, and rising rates of risk factors such as obesity, diabetes, and hypertension. Implantable cardioverter defibrillators (ICDs) help manage cardiovascular diseases (CVDs) by providing life-saving electrical shocks to restore normal heart rhythms in patients at risk of sudden cardiac arrest. For instance, in December 2023, according to the Australian Institute of Health and Welfare, an Australia-based government agency, doctor-certified deaths due to coronary heart disease (CHD) increased to 14,100 in 2021 and further rose to 14,900 in 2022. Therefore, the increasing prevalence of cardiovascular diseases (CVDs) is driving the growth of the implantable cardioverter defibrillators (ICDs) market.
What are the major segments of the implantable cardioverter defibrillators (icds) market?
The implantable cardioverter defibrillators (ICDs) market covered in this report is segmented –
1) By Type: Single Chamber Implantable Cardioverter Defibrillators (ICDs), Dual Chamber Implantable Cardioverter Defibrillators (ICDs), Biventricular Devices
2) By Applications: Bradycardia, Tachycardia, Heart Failure, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Single Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Single Chamber ICDs, MRI-Compatible Single Chamber ICDs, Wireless Single Chamber ICDs
2) By Dual Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Dual Chamber ICDs, MRI-Compatible Dual Chamber ICDs, Wireless Dual Chamber ICDs
3) By Biventricular Devices: CRT-D (Cardiac Resynchronization Therapy Defibrillator), CRT-P (Cardiac Resynchronization Therapy Pacemaker), Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)
Order your report now for swift delivery
Which companies dominate the implantable cardioverter defibrillators (icds) market?
Major companies operating in the implantable cardioverter defibrillators (ICDs) market are Abbott Laboratories, Medtronic Inc., Koninklijke Philips N.V., Boston Scientific Corporation, ZOLL Medical Corporation, St. Jude Medical Inc., BIOTRONIK SE & Co. KG, Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., LivaNova PLC, MicroPort Scientific Corporation, Japan Lifeline Co. Ltd., AtriCure Inc., Physio-Control Inc., BPL Medical Technologies Private Limited, Kestra Medical Technologies Inc., CU Medical Germany GmbH, Metrax GmbH, Intermedics Inc., Sorin Group S.p.A.
How will evolving trends contribute to the growth of the implantable cardioverter defibrillators (icds) market?
Major companies operating in the implantable cardioverter defibrillators (ICDs) market are focusing on technological advancements, such as low current consumption defibrillators, to enhance device efficiency, extend battery life, and improve patient comfort. Low current consumption defibrillators are designed to deliver electrical shocks to the heart using less energy, which helps prolong battery life while ensuring effective treatment of arrhythmias. For instance, in October 2023, MicroPort CRM, a France-based medical devices company, launched the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation lead in Japan, marking a notable advancement in cardiac care technology. These devices feature innovative capabilities, such as low current consumption for prolonged battery life and MRI compatibility, ensuring they are suitable for patients needing imaging procedures. The ULYS ICD includes the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, enhancing patient safety during MRI scans. Additionally, the INVICTA lead achieved a 100% implantation success rate and a 97.4% complication-free rate in clinical trials, highlighting its reliability and effectiveness.
What are the key regional dynamics of the implantable cardioverter defibrillators (icds) market, and which region leads in market share?
North America was the largest region in the implantable cardioverter defibrillators market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardioverter defibrillators (ICDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Implantable Cardioverter Defibrillators (ICDs) Market Report 2025 Offer?
The implantable cardioverter defibrillators (icds) market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Implantable cardioverter defibrillators (ICDs) are small devices implanted under the skin, typically near the chest, designed to monitor the heart’s rhythm and deliver electrical shocks if a life-threatening arrhythmia, such as ventricular fibrillation, is detected. Their purpose is to prevent sudden cardiac arrest by restoring a normal heart rhythm.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20839
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
